AIIMS Delhi Starts Screening Children For Covaxin Trials - Viral Bake

The All India Institute of Medical Sciences Delhi to start screening children whose aged between 2-18years for the clinical trials of Covaxin. Bharat Biotech and ICMR have developed the Covid-19 vaccine. AIIMS Delhi has made this decision after AIIMS Patna, which started the trials recently on children aged between 12 and 18 years.

Source: New Indian Express

AIIMS Delhi has started the children screening for Covaxin trials after getting permission from the Drugs Controller General of India (DCGI). The DCGI department approval also followed by a recommendation by the Subject Expert Committee (SEC) on May 12.

Also Read: U.S. Has Begun The ‘Human Trial’ Of ‘Coronavirus Vaccine’, Here Is All You Need To Know

However, a total of 525 children included in these clinical trials of Covaxin. These children may divided into three different groups. The first group has 175 children whose age is between 12 and 18 years, the second group has 175 children aged between 6 and 12 years, and the third group has another 175 children aged between 2 and 6 years.

These children will receive two doses of the Covaxin vaccine through the intramuscular route. The second dose will be given after 28 days of the first dose.


Like it? Share with your friends!

What's Your Reaction?

hate hate
0
hate
confused confused
0
confused
fail fail
1
fail
fun fun
2
fun
geeky geeky
0
geeky
love love
7
love
lol lol
1
lol
omg omg
3
omg
win win
2
win
Vivek Singh

With over 5 years of writing obituaries for a different organisation, I have a uniquely wry voice that shines through in my newest collection of articles.